These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12865395)

  • 1. Fitness of antibiotic resistant Staphylococcus epidermidis assessed by competition on the skin of human volunteers.
    Gustafsson I; Cars O; Andersson DI
    J Antimicrob Chemother; 2003 Aug; 52(2):258-63. PubMed ID: 12865395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo reduced fitness and virulence in ciprofloxacin-resistant Acinetobacter baumannii.
    Smani Y; López-Rojas R; Domínguez-Herrera J; Docobo-Pérez F; Martí S; Vila J; Pachón J
    Clin Microbiol Infect; 2012 Jan; 18(1):E1-4. PubMed ID: 22084991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitrofurantoin resistance mechanism and fitness cost in Escherichia coli.
    Sandegren L; Lindqvist A; Kahlmeter G; Andersson DI
    J Antimicrob Chemother; 2008 Sep; 62(3):495-503. PubMed ID: 18544599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Restored fitness leads to long-term persistence of resistant Bacteroides strains in the human intestine.
    Löfmark S; Jernberg C; Billström H; Andersson DI; Edlund C
    Anaerobe; 2008 Jun; 14(3):157-60. PubMed ID: 18434218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro inhibition of coagulase-negative staphylococci by vancomycin/aminoglycoside-loaded cement spacers.
    Streuli JC; Exner GU; Reize CL; Merkofer C; Scott CP; Zbinden R
    Infection; 2006 Apr; 34(2):81-6. PubMed ID: 16703297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rifampicin resistance in Staphylococcus epidermidis: molecular characterisation and fitness cost of rpoB mutations.
    Wi YM; Greenwood-Quaintance KE; Brinkman CL; Lee JYH; Howden BP; Patel R
    Int J Antimicrob Agents; 2018 May; 51(5):670-677. PubMed ID: 29287710
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of hypermutability on bacterial fitness and emergence of resistance in experimental osteomyelitis due to Staphylococcus aureus.
    Daurel C; Prunier AL; Chau F; Garry L; Leclercq R; Fantin B
    FEMS Immunol Med Microbiol; 2007 Nov; 51(2):344-9. PubMed ID: 17714489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High prevalence of resistance to fusidic acid in clinical isolates of Staphylococcus epidermidis.
    McLaws F; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2008 May; 61(5):1040-3. PubMed ID: 18299637
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey.
    Koksal F; Yasar H; Samasti M
    Microbiol Res; 2009; 164(4):404-10. PubMed ID: 17475456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of pristinamycin-resistant Staphylococcus epidermidis isolates in the Tunisian Bone Marrow Transplant Center.
    Achour W; Bouchami O; Galopin S; Leclercq R; Ben Hassen A
    Lett Appl Microbiol; 2008 Mar; 46(3):358-63. PubMed ID: 18194160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of the fitness impacts on Escherichia coli of acquisition of antibiotic resistance genes encoded by different types of genetic element.
    Enne VI; Delsol AA; Davis GR; Hayward SL; Roe JM; Bennett PM
    J Antimicrob Chemother; 2005 Sep; 56(3):544-51. PubMed ID: 16040624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibiotic susceptibility among Staphylococcus epidermidis isolated from prosthetic joint infections with special focus on rifampicin and variability of the rpoB gene.
    Hellmark B; Unemo M; Nilsdotter-Augustinsson A; Söderquist B
    Clin Microbiol Infect; 2009 Mar; 15(3):238-44. PubMed ID: 19196261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological profile of linezolid-resistant coagulase-negative staphylococci.
    Potoski BA; Adams J; Clarke L; Shutt K; Linden PK; Baxter C; Pasculle AW; Capitano B; Peleg AY; Szabo D; Paterson DL
    Clin Infect Dis; 2006 Jul; 43(2):165-71. PubMed ID: 16779742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibiotic resistance profile: isolation and characterization of clinical isolates of staphylococci from patients with community-acquired skin infections.
    Bashir A; Mujahid TY; Jehan N
    Pak J Pharm Sci; 2007 Oct; 20(4):299-304. PubMed ID: 17604253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring in vivo fitness of rifampicin-resistant Staphylococcus aureus mutants in a mouse biofilm infection model.
    Yu J; Wu J; Francis KP; Purchio TF; Kadurugamuwa JL
    J Antimicrob Chemother; 2005 Apr; 55(4):528-34. PubMed ID: 15743898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of ciprofloxacin resistance in Escherichia coli in an in vitro kinetic model: relation between drug exposure and mutant prevention concentration.
    Olofsson SK; Marcusson LL; Komp Lindgren P; Hughes D; Cars O
    J Antimicrob Chemother; 2006 Jun; 57(6):1116-21. PubMed ID: 16624874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of the fitness burden of quinolone resistance in Pseudomonas aeruginosa.
    Kugelberg E; Löfmark S; Wretlind B; Andersson DI
    J Antimicrob Chemother; 2005 Jan; 55(1):22-30. PubMed ID: 15574475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit.
    Kelly S; Collins J; Maguire M; Gowing C; Flanagan M; Donnelly M; Murphy PG
    J Antimicrob Chemother; 2008 Apr; 61(4):901-7. PubMed ID: 18272512
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rifampicin resistance and its fitness cost in Enterococcus faecium.
    Enne VI; Delsol AA; Roe JM; Bennett PM
    J Antimicrob Chemother; 2004 Feb; 53(2):203-7. PubMed ID: 14688044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The isoleucyl-tRNA synthetase mutation V588F conferring mupirocin resistance in glycopeptide-intermediate Staphylococcus aureus is not associated with a significant fitness burden.
    Hurdle JG; O'Neill AJ; Chopra I
    J Antimicrob Chemother; 2004 Jan; 53(1):102-4. PubMed ID: 14657089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.